Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Recruiting1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06608511Active Not Recruiting
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
Basal Cell Carcinoma of SkinBasal Cell Carcinoma of Skin, Site UnspecifiedCutaneous Squamous Cell Carcinoma (CSCC)+3 more
PrincipalinvestigatorStart date: 2024-12-11
NCT06199713Recruiting
Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
PrincipalinvestigatorStart date: 2024-01-30
NCT07472322Phase 1/2Not Yet Recruiting
ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1
Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IIIMerkel Cell Carcinoma, Stage IV
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06608511PrincipalInvestigator

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Basal Cell Carcinoma of SkinBasal Cell Carcinoma of Skin, Site UnspecifiedCutaneous Squamous Cell Carcinoma (CSCC)+3 more
Active Not Recruiting
NCT06199713PrincipalInvestigator

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
Recruiting
NCT07472322Phase 1/2PrincipalInvestigator

ASTX727 & Retifanlimab-dlwr for Advanced Merkel Cell After Progression on Anti-PD-(L)1

Merkel Cell CarcinomaMerkel Cell Carcinoma, Stage IIIMerkel Cell Carcinoma, Stage IV
Not Yet Recruiting

All 3 trials loaded